Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Closes Acquisition of Pediatrix's Newborn Screening Business

NEW YORK (GenomeWeb News) – PerkinElmer said Friday that it has completed its acquisition of the newborn metabolic screening business of Pediatrix Medical Group.
The company announced its plans to acquire the business in December in a bid to expand its presence in the neonatal health market.
The acquisition gives PerkinElmer Pediatrix's screening reference laboratory and its StepOne newborn screening product, which analyzes more than 50 inherited disorders in newborns.
The Pediatrix screening lab offers services to hospitals and medical groups in Maryland, Mississippi, Louisiana, Nebraska, Pennsylvania, and the District of Columbia.
PerkinElmer did not disclose the financial terms of the acquisition, but according to a purchase agreement dated Dec. 18, 2007 and filed with the US Securities and Exchange Commission on Feb. 28 as part of its annual report, PerkinElmer planned to pay $66 million to acquire the business.
PerkinElmer said in December that Pediatrix’s screening business generated revenues of around $15 million in 2007.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.